Literature DB >> 28306673

Hypertensive crisis: an update on clinical approach and management.

Emrah Ipek1, Ahmet Afşin Oktay, Selim R Krim.   

Abstract

PURPOSE OF REVIEW: Here, we review current concepts on hypertensive crisis (HTN-C) with a focus on epidemiology, causes, pathophysiology and prognosis. We also offer a practical approach to the management of HTN-C. RECENT
FINDINGS: HTN-C is characterized by a severe and abrupt increase in blood pressure (BP) with impending or progressive acute end-organ damage (EOD). HTN-C can be divided into hypertensive emergency (HTN-E) and hypertensive urgency (HTN-U) based on the presence or absence of acute EOD, respectively. Recent retrospective studies have demonstrated that emergency department (ED) referrals from an outpatient clinic or rapid BP-lowering strategies in the ED do not lead to improved outcomes in patients with HTN-U.
SUMMARY: HTN-C can be a de-novo manifestation or a complication of essential or secondary HTN. The presence of acute EOD is a major poor prognostic indicator in HTN-C. The main objectives of the management of HTN-C are distinction of HTN-E from HTN-U and appropriate risk stratification, prevention or regression of acute EOD due to severely elevated BP, prevention of recurrence of HTN-C with an effective long-term management plan and avoidance of rapid lowering of BP except in some special circumstances. The majority of patients with asymptomatic HTN-U can be safely managed in the outpatient setting without exposing them to the risks of aggressive BP lowering. However, patients with HTN-E require hospitalization, prompt treatment and close monitoring.

Entities:  

Mesh:

Substances:

Year:  2017        PMID: 28306673     DOI: 10.1097/HCO.0000000000000398

Source DB:  PubMed          Journal:  Curr Opin Cardiol        ISSN: 0268-4705            Impact factor:   2.161


  7 in total

Review 1.  The Management of Hypertensive Emergencies-Is There a "Magical" Prescription for All?

Authors:  Ana-Maria Balahura; Ștefan-Ionuț Moroi; Alexandru Scafa-Udrişte; Emma Weiss; Cristina Japie; Daniela Bartoş; Elisabeta Bădilă
Journal:  J Clin Med       Date:  2022-05-31       Impact factor: 4.964

2.  Assessing adequacy of emergency provider documentation among interhospital transferred patients with acute aortic dissection.

Authors:  Mark Rose; Carina Newton; Benchaa Boualam; Nancy Bogne; Adam Ketchum; Umang Shah; Jordan Mitchell; Safura Tanveer; Tucker Lurie; Walesia Robinson; Rebecca Duncan; Stephen Thom; Quincy Khoi Tran
Journal:  World J Emerg Med       Date:  2019

Review 3.  New Developments in Hypertensive Encephalopathy.

Authors:  Joseph B Miller; Kushak Suchdev; Namita Jayaprakash; Daniel Hrabec; Aditya Sood; Snigdha Sharma; Phillip D Levy
Journal:  Curr Hypertens Rep       Date:  2018-02-26       Impact factor: 5.369

4.  Direct assessment of adherence and drug interactions in patients with hypertensive crisis-A cross-sectional study in the Emergency Department.

Authors:  Manuel Wallbach; Nadine Lach; Johanna Stock; Henrik Hiller; Eirini Mavropoulou; Myra-Lynn Chavanon; Hartmud Neurath; Sabine Blaschke; Elena Lowin; Christoph Herrmann-Lingen; Gerhard A Müller; Michael J Koziolek
Journal:  J Clin Hypertens (Greenwich)       Date:  2018-12-05       Impact factor: 3.738

5.  Hypertensive crisis: clinical characteristics of patients with hypertensive urgency, emergency and pseudocrisis at a public emergency department.

Authors:  Angela Maria Geraldo Pierin; Carime Farah Flórido; Juliano Dos Santos
Journal:  Einstein (Sao Paulo)       Date:  2019-08-29

6.  Prevalence of non-steroidal anti-inflammatory drugs (NSAIDs) use in patients with hypertensive crisis.

Authors:  Soodeh Jahangiri; Seyed Hamidreza Mousavi; Mohammad Reza Hatamnejad; Maryam Salimi; Hamed Bazrafshan
Journal:  Health Sci Rep       Date:  2022-01-12

7.  Retinal and Choroidal Capillary Perfusion Are Reduced in Hypertensive Crisis Irrespective of Retinopathy.

Authors:  Jan Henrik Terheyden; Maximilian W M Wintergerst; Carmen Pizarro; Maximilian Pfau; Gabrielle N Turski; Frank G Holz; Robert P Finger
Journal:  Transl Vis Sci Technol       Date:  2020-07-29       Impact factor: 3.283

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.